TITLE:
Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-021)

CONDITION:
Diabetes Mellitus, Type 2

INTERVENTION:
Sitagliptin (MK0431)

SUMMARY:

      The purpose of this clinical study is to determine the safety and efficacy of an
      investigational drug in patients with type 2 diabetes mellitus.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 75 Years
Criteria:

        Inclusion Criteria:

          -  Patients with type 2 diabetes mellitus

          -  Patient is not pregnant or breastfeeding

          -  Male or female patient unlikely to conceive

          -  Patient not on an antihyperglycemic drug

        Exclusion Criteria:

          -  Patient has history of type 1 diabetes mellitus

          -  Patient has history of ketoacidosis

          -  Patient requires insulin within 8 weeks prior to start of study

          -  Patient on weight loss program and is not in maintenance phase

          -  Patient taking weight loss medication within 8 weeks prior to start of study

          -  Patient on or likely to require = 14 days or repeated courses of corticosteroids

          -  Patient taking immunosuppressive/immunomodulating medication

          -  Patient taking digoxin or other cardiac medication

          -  Patient has undergone surgical general anesthesia within 30 days prior to start of
             study

          -  Patient taking investigational drug within 8 weeks prior to start of study

          -  Patient is diagnosed with liver disease

          -  Patient has chronic myopathy, progressive neurological/neuromuscular disorder

          -  Patient has with severe cardiac conditions within the last 6 months

          -  Patient is Human immunodeficiency virus (HIV) positive

          -  Patient has hematological disorder

          -  Patient has history of malignancy

          -  Patient has history of alcohol or drug abuse within the past 3 years
      
